Why is Piramal Pharma falling/rising?

As of 25-Sep, Piramal Pharma Ltd's stock is currently priced at 195.20, reflecting a decrease of 1.2 points or 0.61%. The stock has been on a downward trend, having lost 6.29% over the last four days and is trading below all its moving averages, indicating a bearish sentiment. Despite outperforming its sector by 0.25% today, the stock has shown a significant decline of 26.56% year-to-date and a return of -13.80% over the past year. The company's financials reveal a concerning picture, with a high Debt to EBITDA ratio of 3.21 times and a low Return on Equity of 0.87%, which suggests challenges in servicing debt and low profitability. Additionally, the recent quarterly performance has been poor, with a significant drop in both profit before tax and profit after tax compared to previous quarters.
In the broader market context, Piramal Pharma's short-term performance has been worse than the benchmark, with a 1-week return of -3.98% compared to the Sensex's -2.23%. This underperformance is compounded by a notable decline in investor participation, as evidenced by a 39.07% drop in delivery volume against the 5-day average. While the company has healthy long-term growth prospects with an annual operating profit growth rate of 31.99%, the current financial difficulties and declining stock performance have overshadowed these positives, leading to a cautious outlook among investors.